NCT01334021 2026-03-09Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast CancerM.D. Anderson Cancer CenterPhase 2 Active not recruiting1,100 enrolled
NCT04329065 2025-11-06Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast CancerUniversity of WashingtonPhase 2 Recruiting25 enrolled